FIGURE 2.
Comparison of portal vein thrombosis (PVT) prevalence at the time of listing for liver transplantation as well as at the time of transplantation between patients with O vs non‐O blood types in the “US cohort” (excluding patients with hepatocellular carcinoma [HCC] and/or transjugular intrahepatic portosystemic shunt [TIPS])